MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circgenetics.113.000499

Медицинская библиотека · Circulation. Cardiovascular genetics · 2014

Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.

Saksi Jani, Ijäs Petra, Mäyränpää Mikko I, Nuotio Krista, Isoviita Pia M, Tuimala Jarno, Lehtonen-Smeds Erno, Kaste Markku, Jula Antti, Sinisalo Juha, Nieminen Markku S, Lokki Marja-Liisa, Perola Markus, Havulinna Aki S, Salomaa Veikko, Kettunen Johannes, Jauhiainen Matti, Kovanen Petri T, Lindsberg Perttu J

СтатьяМетаанализПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Fatty acid-binding protein 4 (FABP4 or aP2 in mice) has been identified as a key regulator of core aspects of cardiometabolic disorders, including lipotoxic endoplasmic reticulum stress in macrophages. A functional promoter polymorphism (rs77878271) of human FABP4 gene has been described resulting in reduced FABP4 transcription.

METHODS AND

RESULTS

We investigated the effects of this low-expression variant of FABP4 on cardiovascular morbidity and carotid atherosclerosis on a population level (n=7491) and in patient cohorts representing endarterectomized patients with advanced carotid atherosclerosis (n=92) and myocardial infarction (n=3432). We found that the low-expression variant was associated with decreased total cholesterol levels (P=0.006) with the largest reduction in variant allele homozygotes. Obese variant allele carriers also showed reduced carotid intima-media thickness (P=0.010) and lower prevalence of carotid plaques (P=0.060). Consistently, the variant allele homozygotes showed 8-fold lower odds for myocardial infarction (P=0.019; odds ratio, 0.12; 95% confidence interval, 0.003-0.801). Within the carotid plaques, the variant allele was associated with a 3.8-fold reduction in FABP4 transcription (P=0.049) and 2.7-fold reduction in apoptosis (activated caspase 3; P=0.043). Furthermore, the variant allele was enriched to patients with asymptomatic carotid stenosis (P=0.038). High FABP4 expression in the carotid plaques was associated with lipid accumulation, intraplaque hemorrhages, plaque ulcerations, and phosphoactivated endoplasmic reticulum stress markers.

CONCLUSIONS

Our results reveal FABP4 rs77878271 as a novel variant affecting serum total cholesterol levels and cardiovascular risk. A therapeutic regimen reducing FABP4 expression within the atherosclerotic plaque may promote lesion stability through modulation of endoplasmic reticulum stress signaling, and attenuation of apoptosis, lipid burden, and inflammation.

Для цитирования: Saksi Jani, Ijäs Petra, Mäyränpää Mikko I, Nuotio Krista, Isoviita Pia M, Tuimala Jarno, Lehtonen-Smeds Erno, Kaste Markku, Jula Antti, Sinisalo Juha, Nieminen Markku S, Lokki Marja-Liisa, Perola Markus, Havulinna Aki S, Salomaa Veikko, Kettunen Johannes, Jauhiainen Matti, Kovanen Petri T, Lindsberg Perttu J. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.. Circulation. Cardiovascular genetics. 2014. DOI: 10.1161/circgenetics.113.000499.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.